On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy
Advanced Science · 2025
DOI: 10.1002/advs.202414233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chenglin Liang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, …. Hauptthemen laut MEDLINE: Immunotherapy, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds of Henan Province Foundation for Science and Technology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Although cytotoxic T lymphocytes (CTLs) activation combined with programmed cell death‐1 (PD‐1)/programmed cell death ligand‐1 (PD‐L1) axis blockade have emerged as an effective strategy to improve immunotherapeutic potency, it remains challenging to realize the spatiotemporal synergy of these two components. Herein, the study reports an engineered bacterial‐based delivery system that can simultaneously promote CTLs infiltration and control PD‐L1 binding protein (PD‐L1 trap) release on demand at tumor site. The drug release button of this tumor targeting system is the specific temperature, which is accomplished by dual‐modified melanin nanoparticles with photothermal conversion capacity on the engineered bacterial. These dual‐modified nanoparticles can form in situ reservoir of heat supplier and antitumor immunity activator once arriving at tumor microenvironment (TME). Importantly, the study establishes the personalized administration regimen according to TME changes, and perform local laser irradiation to trigger PD‐L1 trap production only in TME when infiltrated CTLs reach the highest level. This work provides a flexible platform for optimizing cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Key Laboratory of Targeting Therapy and Diagnosis for Critical Diseases, Zhengzhou University, Zhengzhou, 450001, China.
ORCID-Profile: Lin Hou
Förderung
- Joint Funds of Henan Province Foundation for Science and Technology
- National Natural Science Foundation of China
Zitieren
APA
Liang, C., Yang, H., Li, T., Jiang, X., Li, X., Gao, C., & Hou, L. (2025). On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202414233
Vancouver
Liang C, Yang H, Li T, Jiang X, Li X, Gao C, et al. On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202414233
BibTeX
@article{Liang2025,
author = {Liang, Chenglin and Yang, Hanxiao and Li, Tongtong and Jiang, Xiaojuan and Li, Xinni and Gao, Chen and Hou, Lin},
title = {On‐Demand Controlled Release Multi‐Drugs Delivery System for Spatiotemporally Synergizing Antitumor Immunotherapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202414233}
}
EUVIMED